Northwestern Medicine scientists have developed the first animal model for ALS dementia, a form of ALS that also damages the brain, allowing for direct monitoring of test drugs to determine if they work.
Dane Chetkovich, MD, PhD, and Brian Mustanski, PhD, are the latest of many faculty members who are members of National Institutes of Health (NIH) study sections, through which they peer review NIH research grant applications.
Northwestern Medicine scientists identified a previously unknown signaling pathway that enhances tumor growth in glioblastomas and head and neck cancers. The proteins in the pathway could be targeted in the treatment of human cancers.
Scientists from Northwestern Medicine have discovered a key function for the CRAC channel, which transports calcium into cells.
The Les Turner ALS Foundation made a $10 million commitment to create the Les Turner ALS Research and Patient Center at Northwestern Medicine to accelerate research and advance patient care in amyotrophic lateral sclerosis, also known as Lou Gehrig’s Disease.
Northwestern Medicine scientists found stimulating a particular region in the brain via non-invasive delivery of electrical current using magnetic pulses improves memory.
A new Northwestern Medicine study reports mindfulness training for individuals with early-stage dementia and their caregivers was beneficial, easing depression and improving sleep and quality of life in both groups.
Northwestern Medicine investigators found that depressive symptoms were under-recognized and under-treated for many patients with Parkinson’s disease.
Northwestern Medicine study finds office workers with more light exposure at work had improved sleep, physical activity and quality of life than workers with less light exposure.
A mathematical model can predict whether a tumor has a gene mutation associated with a favorable prognosis for glioblastoma patients.